The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2017
DOI: 10.1101/mcs.a001842
|View full text |Cite
|
Sign up to set email alerts
|

New tools and approaches to newborn screening: ready to open Pandora's box?

Abstract: The landscape of newborn screening (NBS) is changing as new tools are developed. We must acknowledge that NBS is a very important and extraordinarily positive initiative especially for rare and serious inherited disorders; however, lessons learned from current NBS should guide the future of NBS as we enter the era of “omics” that will expand NBS for many other genetic disorders. In this article, I will first discuss new tools such as genomics and metabolomics for NBS. I will then turn to assessing how best to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(18 citation statements)
references
References 32 publications
0
17
0
1
Order By: Relevance
“…Screening metabolite abundances in the blood of newborns has allowed clinicians to effectively ameliorate potentially devastating effects of inborn errors of metabolism since the 1960s by reducing the time to diagnose and treat these disorders that occur in thousands of infants per year [4,5]. By applying targeted mass spectrometry (MS) techniques, 49 inborn errors of metabolism can be identified at birth [6]. This highly successful program clearly demonstrates the utility of detecting abnormalities in the concentrations of small molecules, and that metabolomics data can transition into practical diagnostic tests.…”
Section: Introductionmentioning
confidence: 99%
“…Screening metabolite abundances in the blood of newborns has allowed clinicians to effectively ameliorate potentially devastating effects of inborn errors of metabolism since the 1960s by reducing the time to diagnose and treat these disorders that occur in thousands of infants per year [4,5]. By applying targeted mass spectrometry (MS) techniques, 49 inborn errors of metabolism can be identified at birth [6]. This highly successful program clearly demonstrates the utility of detecting abnormalities in the concentrations of small molecules, and that metabolomics data can transition into practical diagnostic tests.…”
Section: Introductionmentioning
confidence: 99%
“…One important component of this system is the panel of screening tests itself. However, new tests are being added to screening panels without the funding or infrastructure needed to provide adequate care, follow-up, and clinical services to newborns and their families in the event of a positive result [13]; only one component of the system is being strengthened, with little attention to other equally or even more important ones. It is noteworthy that many health professionals still also have little or marginal understanding of neonatal screening.…”
Section: Discussionmentioning
confidence: 99%
“…The internal standards, as well as the extraction solution, were obtained from the NeoBase 2Non-Derivatized MSMS Kit (Perkin Elmer Life and Analytical Sciences, Turku, Finland). Mass spectra were acquired in positive electrospray ionization, using multiple reaction monitoring (MRM) as acquisition mode, using an Ultra-Performance Liquid Chromatography/Tandem Quadrupole Mass Spectrometry (UPLC/MS/MS) system (Acquity UPLC I-Class coupled to a Xevo TQD, Waters Corp., Manchester, UK) [7][8][9]. Data were processed by MassLynx V4.2 and NeoLynx Software (Water Corp.).…”
Section: Newborn Screening Testmentioning
confidence: 99%
“…In order to evaluate the metabolic alterations, further analyses for diagnostic confirmation were performed. UK) [7][8][9]. Data were processed by MassLynx V4.2 and NeoLynx Software (Water Corp.).…”
Section: Newborn Screening Testmentioning
confidence: 99%